Beta Thalassemia and Sickle Cell Anemia

Back to Curriculum

Beta Thalassemia and Sickle Cell Anemia are inherited blood disorders caused by mutations in the HBB gene, which provides instructions for making beta-globin, a component of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen throughout the body.

Beta Thalassemia results from reduced or absent production of beta-globin chains. The severity ranges from mild (beta thalassemia minor/trait) to severe (beta thalassemia major or Cooley's anemia). People with thalassemia major require regular blood transfusions and medical care to manage iron overload and other complications.

Sickle Cell Anemia is caused by a specific mutation that results in abnormal hemoglobin (hemoglobin S). Under certain conditions, red blood cells become rigid and sickle-shaped, causing them to block blood flow. This leads to pain crises, organ damage, increased risk of infections, and chronic anemia.

Both conditions are inherited in an autosomal recessive pattern. Carriers (those with one affected gene) often have mild or no symptoms but can pass the condition to their children. Interestingly, being a carrier of either condition provides some protection against malaria, which explains why these mutations are more common in populations from malaria-endemic regions.

NutraHacker examines the following gene related to Beta Thalassemia and Sickle Cell Anemia:

For more information about your own genetic profile as related to these blood disorders, please check out our NutraHacker Carrier Status and Drug Response Report.

Or to get going without any further delay, upload raw DNA data and find out more about your carrier status today.